NK cells for cancer immunotherapy

2020/01/06 by Noriko Shimasaki, Amit Jain, Dario Campana · 6 citations
Immunology and Microbiology · Medicine · #CAR-T cell therapy research #Immune Cell Function and Interaction #T-cell and B-cell Immunology

paper · doi:10.1038/s41573-019-0052-1

crossref issued 2020/01/06 · crossref published 2020/01/06 · crossref published-online 2020/01/06 · openalex publication_date 2020/01/06 · crossref created 2020/01/06 · crossref published-print 2020/03/01 · crossref deposited 2023/09/24 · openalex created_date 2025/10/10 · crossref indexed 2026/07/28 · openalex updated_date 2026/07/29

Cited by

• Chimeric antigen receptor natural killer cell therapy: A systematic review of preclinical studies for hematologic and solid malignancies
• Inflammation and tumor progression: signaling pathways and targeted intervention
• Nanoparticle-mediated efficient up-regulation of GSDMD-N to induce pyroptosis and enhance NK cell-based cancer immunotherapy
• Protocol for assessing immune-target cell interactions using a single-cell cytotoxicity assay
• Low-intensity Pulsed Ultrasound Enhances NK Cell Adoptive Therapy by Modulating the Wnt/β-catenin Signaling Pathway
• Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion